Additionally, patients with SLE, LA, and aβ2GPI IgA antibodies are also associated with developing thrombosis and aCL with preterm delivery (Saleh et al., 2020; Demir et al., 2021). This evidence concerns the gene CD79A and deep vein thrombosis.